Inify Laboratories announced to be on track in building its first ultramodern laboratory at Campus Solna, Sweden, next to world-leading healthcare. The company expects to move into the new facility during the fourth quarter of 2022 and to immediately commence installation of systems and equipment, followed by accreditation. The laboratory will begin production of prostate cancer diagnoses according to plan - sometime during the first half of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.95 NOK | -0.62% | -14.05% | -35.89% |
2023 | Inify Laboratories Launches AI-Powered Cancer Diagnostic Services | MT |
2023 | Inify Laboratories Announces the Opening of Its First Laboratory | CI |
1st Jan change | Capi. | |
---|---|---|
-35.89% | 34.57M | |
+7.32% | 217B | |
+13.83% | 194B | |
+20.48% | 143B | |
+31.33% | 111B | |
+3.08% | 64.3B | |
+14.64% | 52.94B | |
+2.72% | 49.53B | |
-5.88% | 38.31B | |
+0.25% | 35.22B |
- Stock Market
- Equities
- INIFY Stock
- News INIFY Laboratories AB
- Inify Laboratories on Track in Building Its First Ultramodern Laboratory At Campus Solna, Sweden